EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis

Seong-il Oh

Journal of the Korean Neurological Association · 01.05.2026 · 44 (2) · 124-133

DOI: 10.17340/jkna.2025.0062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Korean Neurological Association, online erschienen am 01.05.2026. Verfasst von Seong-il Oh. Die Arbeit nennt 58 Literaturangaben. Gefördert von: CN Research Foundation for Rare Disease.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment paradigm for neuromuscular diseases, especially myasthenia gravis and amyotrophic lateral sclerosis, has recently shifted with the emergence of mechanism-based and precision therapies. In myasthenia gravis, improved understanding of antibody-mediated pathology has enabled the clinical adoption of targeted immunotherapies, including complement inhibitors and neonatal Fc receptor antagonists, resulting in meaningful benefits for refractory disease and a shift beyond conventional immunosuppression. In amyotrophic lateral sclerosis, while multidisciplinary care remains fundamental, recent advances highlight a gradual move toward precision medicine through platform trial designs, biomarker-informed evaluation, and gene-specific molecular therapies for selected patient subgroups. Together, these developments reflect a paradigm shift from uniform treatment strategies to individualized, pathophysiology-driven clinical decision-making. This review summarizes recent guideline updates and key clinical trial evidence, illustrating how advances in immunopathology, genetics, and trial methodology are redefining contemporary neuromuscular care.

Förderung

  • CN Research Foundation for Rare Disease

Zitieren

APA

Oh, S. (2026). Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis. Journal of the Korean Neurological Association, 44(2), 124-133. https://doi.org/10.17340/jkna.2025.0062

Vancouver

Oh S. Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis. Journal of the Korean Neurological Association. 2026;44(2):124-133. doi:10.17340/jkna.2025.0062

BibTeX
@article{Oh2026,
  author = {Oh, Seong-il},
  title = {Therapeutic Paradigm Changes in Myasthenia Gravis and Amyotrophic Lateral Sclerosis},
  journal = {Journal of the Korean Neurological Association},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {124--133},
  doi = {10.17340/jkna.2025.0062}
}
Kostenlos starten →